This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05945784
Recruitment Status : Completed
First Posted : July 14, 2023
Last Update Posted : December 6, 2023
Sponsor:
Information provided by (Responsible Party):
Emily Rosario, Casa Colina Hospital and Centers for Healthcare

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to investigate the accessibility of beauty products for individuals with upper extremity disabilities. By examining various factors such as packaging design, product applicators, and ease of use, this research aims to identify barriers faced by individuals with upper extremity disabilities or visual deficits when using beauty products. The study seeks to provide insights and recommendations for improving the accessibility of beauty products, ultimately promoting inclusivity and enhancing the overall beauty experience for individuals with disabilities.

Condition or disease Intervention/treatment
Stroke, Ischemic Stroke Hemorrhagic Stroke (CVA) or TIA Stroke, Acute Traumatic Brain Injury SCI - Spinal Cord Injury Ehlers-Danlos Syndromes (EDS) Lupus Erythematosus Guillain-Barre Syndrome Multiple Sclerosis Myasthenia Gravis Amyotrophic Lateral Sclerosis Graves Disease Muscular Dystrophies Other: Use of Rare Beauty makeup products

Detailed Description:

Individuals with upper extremity disabilities face unique challenges when it comes to using beauty products. These disabilities can include conditions such as limb loss, limited mobility, or dexterity impairments, which can significantly impact their ability to engage in self-care and beauty routines. The accessibility of beauty products is crucial to ensure that individuals with upper extremity disabilities have equal opportunities to participate in activities that promote self-expression and confidence.

Research in the field of accessible design has highlighted the importance of inclusive product development across various industries, including cosmetics and personal care. However, limited attention has been given specifically to beauty products and their usability for individuals with upper extremity disabilities.

To address this gap, studies are being conducted to assess the accessibility of beauty products and identify potential barriers and solutions. These studies typically examine factors such as packaging design, ergonomics of product applicators, ease of grip, and maneuverability. By understanding the specific challenges faced by individuals with upper extremity disabilities, researchers can propose modifications and design considerations that enhance accessibility.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 57 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Exploring Accessible Beauty: A Study on Enhancing Beauty Product Accessibility for Individuals With Upper Extremity Deficits
Actual Study Start Date : July 21, 2023
Actual Primary Completion Date : September 15, 2023
Actual Study Completion Date : September 29, 2023

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Minimal to moderate upper extremity deficits
  • Individuals aged 18 years to 55 years.
  • Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments.
  • Regular users of beauty products.
  • Able to understand and communicate in the language of the study.
 Other: Use of Rare Beauty makeup products
Participants will be provided with a selection of beauty products items including foundation, concealer, blush, highlighter, and lipstick, specifically chosen for their potential accessibility features. They will have a specified trial period during which they can use the products as part of their regular beauty routines.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Likert Scale [ Time Frame: Complete on Day 7 ]
    It is a validated self-reported instrument to assess packaging of the makeup. A few questions will focus on shape of the cap, length of the wand, shape of the doe foot, finish of the components, how it affects grip, and weight of the component/applicator. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).

  2. Likert Scale [ Time Frame: Complete on Day 14 ]
    It is a validated self-reported instrument to assess packaging of the makeup. A few questions will focus on shape of the cap, length of the wand, shape of the doe foot, finish of the components, how it affects grip, and weight of the component/applicator. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).

  3. Pre-test Questionnaire [ Time Frame: At baseline ]
    Participants will complete questionnaires that assess their demographics, disability characteristics, and previous experiences with beauty products.

  4. Accessibility Evaluation [ Time Frame: Day 7, after use of beauty products ]
    Participants will evaluate the beauty products based on predefined criteria, including ease of grip, maneuverability, packaging design, and product applicators. They will document their experiences, challenges faced, and any suggestions for improvements. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).

  5. Accessibility Evaluation [ Time Frame: Day 14, after use of beauty products at end of study ]
    Participants will evaluate the beauty products based on predefined criteria, including ease of grip, maneuverability, packaging design, and product applicators. They will document their experiences, challenges faced, and any suggestions for improvements. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).

  6. Post-test Questionnaire [ Time Frame: Day 14, after use of beauty products at end of study ]
    Participants will assess changes in their perceptions and experiences with the beauty products. This will include questions about satisfaction, usability, and any perceived improvements in accessibility. Possible scores range from 1 (strongly disagree) to 5 (strongly agree).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
A convenience sample of individuals aged 18 and above, with upper extremity deficits, will be recruited for this study. Efforts will be made to include participants with a range of upper extremity deficits and experiences with beauty products.
Criteria

Inclusion Criteria:

Individuals aged 18 years to 55 years.

  • Minimal to moderate upper extremity deficits, including but not limited to limited mobility or dexterity impairments.
  • Regular users beauty products.
  • Able to understand and communicate in the language of the study.

Exclusion Criteria:

  • Individuals below 18 years of age or over the age of 55.
  • Individuals without upper extremity deficits or with severe upper extremity deficits that may affect the participant's ability to engage in study activities.
  • Participants who are not regular users of beauty products.
  • Inability to understand and communicate in the language of the study.
  • Any medical or psychological condition that may affect the participant's ability to provide informed consent or engage in the study activities safely.
  • Individuals who experience facial skin or eye irritation reported by subject or observed by evaluator at baseline visit
  • History of allergic reactions, and/or known allergies to cosmetic ingredients, toiletries, sunscreens, etc.
  • Immunocompromised subjects
  • Individuals who may experience changes in hormones, such as just those using oral contraception for less than three months before the screening visit or who have changed hormonal contraceptive methods within the three months before the Baseline visit or planning to modify hormonal contraception treatment within the duration of the study.
  • Known to be pregnant, lactating or planning to become pregnant within six months. Subjects who become pregnant during the study must inform the Principal Investigator immediately.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05945784


Locations
Layout table for location information
United States, California
Casa Colina Hospital and Centers for Healthcare
Pomona, California, United States, 91767
Sponsors and Collaborators
Casa Colina Hospital and Centers for Healthcare
Investigators
Layout table for investigator information
Principal Investigator: Emily Rosario, PhD Casa Colina Hospital and Centers for Healthcare
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications:
Skelton H, Gill S, Al Zidjaly N, et al. Exploring the Accessibility of Beauty Products for Individuals with Mobility Disabilities. J Appl Cosmetol. 2020;38(3):65-72.
Smith A, Johnson R, Thompson A, et al. Enhancing Accessibility: Designing Inclusive Beauty Products for All Abilities. J Inclusive Design. 2021;1(2):89-102
Chen L, Kim D, Park J, et al. A Review on Product Accessibility Evaluation Methods for People with Disabilities. Int J Ind Ergon. 2019;71:103-117. doi:10.1016/j.ergon.2018.11.007

Layout table for additonal information
Responsible Party: Emily Rosario, Executive Director, Casa Colina Hospital and Centers for Healthcare
ClinicalTrials.gov Identifier: NCT05945784    
Other Study ID Numbers: IRB: 000000001
First Posted: July 14, 2023    Key Record Dates
Last Update Posted: December 6, 2023
Last Verified: December 2023
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Emily Rosario, Casa Colina Hospital and Centers for Healthcare:
upper extremity disabilities
limited mobility
dexterity impairments
muscle weakness
Additional relevant MeSH terms:
Layout table for MeSH terms
Myasthenia Gravis
Muscular Dystrophies
Stroke
Multiple Sclerosis
Brain Injuries
Spinal Cord Injuries
Brain Injuries, Traumatic
Motor Neuron Disease
Amyotrophic Lateral Sclerosis
Ischemic Stroke
Guillain-Barre Syndrome
Hemorrhagic Stroke
Graves Disease
Ehlers-Danlos Syndrome
Syndrome
 Sclerosis
Wounds and Injuries
Disease
Pathologic Processes
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases